| 000 | 01361 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514042535.0 | ||
| 264 | 0 | _c20020911 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0735-7907 | ||
| 024 | 7 |
_a10.1081/cnv-120002499 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilowsky, Matthew I | |
| 245 | 0 | 0 |
_aEstramustine plus a taxane for advanced prostate cancer: the new standard therapy? _h[electronic resource] |
| 260 |
_bCancer investigation _c2002 |
||
| 300 |
_a849-50 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEstramustine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTaxoids |
| 700 | 1 | _aNanus, David M | |
| 773 | 0 |
_tCancer investigation _gvol. 20 _gno. 5-6 _gp. 849-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/cnv-120002499 _zAvailable from publisher's website |
| 999 |
_c12078775 _d12078775 |
||